With support from JDRF funding, Capillary Biomedical will collaborate with Thomas Jefferson University to develop and test new insulin infusion techno ...

A recently published paper details the safety and efficacy of nusinersen administration via a subcutaneous intrathecal catheter system (SIC) for SMA patients with advanced disease. SMA is a ...

This review highlights new developments in cardiac implantable electronic devices, with an emphasis on pacemakers, newer modes of pacing, and implantable cardioverter–defibrillators.

The subcutaneous implantable cardioverter–defibrillator (ICD) is associated with fewer lead-related complications than a transvenous ICD; however, the subcutaneous ICD cannot provide bradycardia ...

Both McCormick and Hawes hope that the evidence from the new study will accelerate the adoption of SecurAcath, currently the only subcutaneous anchor securement system, reducing unplanned catheter ...

Biogen has partnered with Alcyone Therapeutics to improve the delivery of its spinal muscular atrophy drug Spinraza, handing over $10 million upfront for a global license to an implantable device. ...

The Subcutaneous Implantable Cardioverter‑Defibrillator System Post Approval Study (S‑ICD PAS), which observed patients with subcutaneous implantable cardioverter-defibrillators (S‑ICDs) for ...